Charles Harding

Charles represents academic organisations, SMEs and blue chip companies before the UKIPO and the EPO in patent matters in the life sciences sector. His portfolio covers various technologies such as molecular biology, immunology, biotechnology, virology, veterinary science and food science, through to protein chemistry, chemistry, pharmacology, pharmaceuticals and devices. After more than 35 years in the sector, he is still passionate about working with innovative clients who are breaking new ground and making a genuine difference. Charles has an extensive practice in EPO oppositions and appeals, with over 25 years' advocacy experience including representation before the EPO Enlarged Board of Appeal. He has been involved in litigation (including at first instance and appellate level) in the UK, France, Germany, USA, South Africa and Japan and has also attended interviews at the US Patent Office. Charles has frequently chaired and lectured at numerous international conferences and conventions on issues concerning patents in the life sciences. He has been giving lectures at Queen Mary, University of London to candidates wishing to become European patent attorneys since the 1990s. · D Young & Co LLP

EnglandIntellectual Property, Patents

Email Call Website

About

Charles Harding is a partner at D Young & Co LLP who represents academic organisations, SMEs and blue-chip companies before the UKIPO and the EPO in patent matters in the life sciences sector. He has more than 35 years' experience, an extensive practice in EPO oppositions and appeals (including representation before the EPO Enlarged Board of Appeal), international litigation, and lectures on European patent practice at Queen Mary University of London.

Practice areas

Intellectual PropertyPatentsLife SciencesBiotechnologyPharmaceuticalsLitigation

Office

England

D Young & Co LLP · Charles represents academic organisations, SMEs and blue chip companies before the UKIPO and the EPO in patent matters in the life sciences sector. His portfolio covers various technologies such as molecular biology, immunology, biotechnology, virology, veterinary science and food science, through to protein chemistry, chemistry, pharmacology, pharmaceuticals and devices. After more than 35 years in the sector, he is still passionate about working with innovative clients who are breaking new ground and making a genuine difference. Charles has an extensive practice in EPO oppositions and appeals, with over 25 years' advocacy experience including representation before the EPO Enlarged Board of Appeal. He has been involved in litigation (including at first instance and appellate level) in the UK, France, Germany, USA, South Africa and Japan and has also attended interviews at the US Patent Office. Charles has frequently chaired and lectured at numerous international conferences and conventions on issues concerning patents in the life sciences. He has been giving lectures at Queen Mary, University of London to candidates wishing to become European patent attorneys since the 1990s.

England

Expertise

Molecular biologyImmunologyBiotechnologyVirologyVeterinary scienceFood scienceProtein chemistryChemistryPharmacologyPharmaceuticalsMedical devicesMRI contrast agentsEPO oppositions and appealsAdvocacy before EPO Enlarged Board of AppealRepresentation before the Unified Patent Court

Education

Imperial College — BSc (Hons) Chemistry and Biochemistry
University of London — PhD in medical research (MRI contrast agents)

Admissions

Chartered Patent Attorney (1990)
European Patent Attorney (1991)
Representative before the Unified Patent Court (2024)
Member, Chartered Institute of Patent Attorneys (CIPA)
Member, European Patent Institute (epi)
Fellow of the Royal Society of Chemistry (RSC)